RPRX
Royalty Pharma plc · Healthcare
EVP, Research, Investments Marshall Urist sold $805K of Royalty Pharma plc
Sold$805,110
$40.26Price
20,000Shares
−30%Stake
What RPRX did after the filing
- The stock from Tue, Jan 27 open, $40.11
- +15.9%
- S&P 500, same days
- −2.6%
Measured over 30 trading days, to the Mar 11 close.
Traded Fri, Jan 23. Filed Mon, Jan 26, 4:10 PM ET, after the close. Returns use the Jan 27 open and the Mar 11 close. Not investment advice.